Pasithea Therapeutics Corp. (KTTA)

NASDAQ: KTTA · IEX Real-Time Price · USD

5.16

-0.01 (-0.29%)

At close: Jul 2, 2024, 4:00 PM

5.00

-0.16 (-3.01%)

After-hours: Jul 2, 2024, 5:24 PM EDT

Pasithea Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Net Income	-15.96	-13.94	-2.17	-0.04
Depreciation & Amortization	0.65	0.01	0	0
Share-Based Compensation	0.59	0.84	0.47	0
Other Operating Activities	1.91	1.2	-1.47	0
Operating Cash Flow	-12.81	-11.89	-3.17	-0.04
Capital Expenditures	0.08	-0.11	-0.02	0
Acquisitions	0	-2.19	0	0
Investing Cash Flow	0.08	-2.3	-0.02	0
Share Issuance / Repurchase	-3.73	-3.21	57.24	0.28
Other Financing Activities	-	-	-1.31	-
Financing Cash Flow	-3.73	-3.21	55.93	0.28
Exchange Rate Effect	-0	0.01	-0.01	0
Net Cash Flow	-16.76	-19.81	52.72	0.24
Free Cash Flow	-12.74	-12	-3.2	-0.04
Free Cash Flow Margin	-	-	-21216.05%	-
Free Cash Flow Per Share	-10.39	-9.51	-6.14	-0.10

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).